AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
IND Edition 
⚠
✓
Cryoport Inc (NASDAQ:CYRX)
16.19 USD
+0.190 1.188%Sponsored Reports
Loading...
| Previous Close (in USD) | 16 |
|---|---|
| Change | +0.190 1.188% |
| 52 W H/L (in USD) | 11.450/5.310 |
| EBITDA (in USD) | -3.916M |
| PE Ratio | -- |
| Volume | 568115 |
| Diluted Eps TTM | -0.84 |
| Total Assets (in USD) | 764.989M |
|---|---|
| Total Liabilities (in USD) | 262.351M |
| Revenue TTM (in USD) | 176.177M |
| Cash (in USD) | 250.494M |
| Market Cap (in USD) | 534.736 M |
| Revenue Per Share TTM | 3.518 |
| Gross Profit TTM (in USD) | 83.054M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Cryoport Inc
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
Employees: 684
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Jerrell W. Shelton | Chairman, Pres & CEO | 1945 |
| 2. | Mr. Robert S. Stefanovich | Sr. VP, CFO, Treasurer & Corp. Sec. | 1965 |
| 3. | Dr. Mark W. Sawicki Ph.D. | Sr. VP & Chief Scientific Officer | NA |
| 4. | Tony Ippolito | VP & Gen. Counsel | NA |
| 5. | Mr. Thomas J. Heinzen | VP of Corp. Devel. | NA |
| 6. | Mr. Bret Bollinger | Chief Technology Officer of Cryoport Systems, LLC | 1967 |
| 7. | Mr. Phil Wilson | Chief Operating Officer of Cryoport Systems, LLC | NA |
| 8. | Mr. Raymond Takahashi M.D. | Exec. Officer | NA |
| 9. | Mr. David Petreccia M.D. | Exec. Officer | NA |
| 10. | Mr. Bret Bollinger | VP & Chief Innovation Officer | 1967 |
Peers
Sector: Industrials
Industry: Integrated Freight & Logistics
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
UPS
United Parcel Service Inc |
-0.415 0.384% | 108.04 | 16.030 | 15.924 | 1.437 | 6.976 | 1.632 | 10.042 |
|
FDX
FedEx Corporation |
+5.720 1.796% | 317.91 | 21.060 | 17.857 | 1.024 | 3.159 | 1.394 | 11.613 |
|
DHLGY
Deutsche Post AG |
+0.190 0.640% | 29.65 | 16.100 | 15.723 | 0.782 | 2.517 | 0.952 | 7.032 |
|
DSDVY
DSV Panalpina A/S ADR |
+1.450 1.224% | 117.73 | 48.350 | 24.631 | 0.262 | 3.459 | 1.985 | 20.028 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Income Before Tax | -32.17M | -99.348M | -35.094M | -35.094M | -273.842M |
| Minority Interest | - | - | - | - | - |
| Net Income | 70.301M | -99.587M | -37.333M | -37.333M | -275.528M |
| Selling General Administrative | 102.819M | 148.978M | 140.701M | 120.055M | 97.563M |
| Gross Profit | 83.054M | 99.332M | 103.873M | 103.873M | 96.577M |
| Reconciled Depreciation | 27.712M | 30.757M | 26.172M | 22.765M | 20.247M |
| Ebit | -36.806M | -93.845M | -28.952M | -31.904M | -17.829M |
| Ebitda | -11.653M | -66.358M | -6.187M | -37.426M | -20.652M |
| Depreciation And Amortization | 25.153M | 27.487M | 22.765M | -5.522M | -2.823M |
| Operating Income | -36.806M | -115.157M | -31.904M | -31.904M | -17.829M |
| Other Operating Expenses | 212.983M | 348.412M | 269.181M | 269.181M | 240.437M |
| Interest Expense | 2.361M | 5.503M | 6.142M | 6.142M | 4.689M |
| Tax Provision | 1.799M | 1.276M | 3.075M | 2.239M | 1.686M |
| Interest Income | - | - | - | - | - |
| Net Interest Income | -2.361M | -4.108M | -5.653M | -6.142M | -4.689M |
| Income Tax Expense | 1.799M | 0.239M | 2.239M | 2.239M | 1.686M |
| Total Revenue | 176.177M | 233.255M | 237.277M | 237.277M | 222.608M |
| Total Operating Expenses | 119.86M | 214.489M | 135.777M | 135.777M | 114.406M |
| Cost Of Revenue | 93.123M | 133.923M | 133.404M | 133.404M | 126.031M |
| Total Other Income Expense Net | 4.636M | 15.809M | -3.19M | -3.19M | -256.013M |
| Net Income From Continuing Ops | -33.969M | -114.756M | -46.634M | -37.333M | -275.528M |
| Net Income Applicable To Common Shares | - | - | - | -45.333M | -283.724M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Total Assets | 764.989M | 703.492M | 957.744M | 1038.746M | 1112.97M |
| Intangible Assets | 138.082M | 170.464M | 194.382M | 191.009M | 201.427M |
| Other Current Assets | 8.419M | 11.574M | 10.077M | 9.317M | 8.804M |
| Total Liab | 262.351M | 301.594M | 468.721M | 482.908M | 471.142M |
| Total Stockholder Equity | 502.638M | 401.898M | 489.023M | 555.838M | 641.828M |
| Other Current Liab | 12.98M | 16.941M | 12.441M | 8.458M | 9.912M |
| Common Stock | 0.05M | 0.05M | 0.049M | 0.048M | 0.05M |
| Capital Stock | 42.325M | 34.325M | 26.324M | 18.323M | 10.325M |
| Retained Earnings | -688.884M | -757.175M | -642.419M | -542.832M | -467.541M |
| Good Will | 22.4M | 51.66M | 108.403M | 151.117M | 146.954M |
| Other Assets | - | - | 0M | 1.964M | 1.369M |
| Cash | 250.494M | 45.289M | 46.346M | 36.595M | 139.101M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 219.018M | 64.563M | 45.61M | 40.851M | 42.645M |
| Current Deferred Revenue | 0.943M | 1.106M | 1.308M | 0.439M | 0.547M |
| Net Debt | -19.776M | 205.414M | 369.657M | 399.313M | 287.954M |
| Short Term Debt | 189.812M | 20.348M | 5.806M | 3.908M | 3.603M |
| Short Long Term Debt | 185.257M | 14.441M | 0.149M | 0.128M | - |
| Short Long Term Debt Total | 230.718M | 250.703M | 416.003M | 435.908M | 427.055M |
| Other Stockholder Equity | 1152.68M | 1145.677M | 1131.183M | 1114.896M | 1100.287M |
| Property Plant Equipment | - | - | - | 90.48M | 69.704M |
| Total Current Assets | 476.174M | 341.571M | 535.112M | 604.176M | 693.516M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | 160.714M | 216.46M | 410.409M | 486.728M | 489.698M |
| Net Receivables | 33.359M | 45.778M | 42.074M | 43.858M | 39.412M |
| Long Term Debt | 1.087M | 185.033M | 379.888M | 407.063M | 405.257M |
| Inventory | 23.188M | 22.47M | 26.206M | 27.678M | 16.501M |
| Accounts Payable | 15.283M | 26.168M | 26.055M | 28.046M | 28.583M |
| Accumulated Other Comprehensive Income | -3.483M | -20.929M | -26.065M | -34.549M | -1.243M |
| Non Currrent Assets Other | 2.092M | 2.902M | 1.68M | 1.017M | 1.369M |
| Non Current Assets Total | 288.815M | 361.921M | 422.632M | 434.57M | 419.454M |
| Capital Lease Obligations | 44.374M | 51.229M | 35.966M | 28.717M | 21.798M |
| Long Term Debt Total | - | - | - | - | - |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
|---|---|---|---|---|---|
| Investments | 59.589M | 176.815M | 57.929M | -59.681M | -438.707M |
| Total Cashflows From Investing Activities | 250.323M | 176.815M | 36.045M | -59.681M | -469.254M |
| Total Cash From Financing Activities | -21.074M | -161.531M | -23.798M | -39.174M | 564.342M |
| Net Income | 70.301M | -114.756M | -99.587M | -37.333M | -275.528M |
| Change In Cash | 205.205M | -1.057M | 9.751M | -102.506M | 102.228M |
| Begin Period Cash Flow | 45.289M | 46.346M | 36.595M | 139.101M | 36.873M |
| End Period Cash Flow | 250.494M | 45.289M | 46.346M | 36.595M | 139.101M |
| Total Cash From Operating Activities | -8.58M | -16.323M | -0.757M | -1.851M | 8.126M |
| Depreciation | 27.712M | 30.757M | 27.487M | 22.765M | 20.247M |
| Other Cashflows From Investing Activities | 206.47M | -4.326M | -5.139M | 3M | -6.665M |
| Dividends Paid | 8M | 8M | 8M | -8M | -8.196M |
| Change To Inventory | -2.185M | 3.252M | 1.508M | -14.204M | -5.979M |
| Sale Purchase Of Stock | -10.011M | 0M | 23.596M | -37.96M | 8.196M |
| Other Cashflows From Financing Activities | 8M | 8M | 1.478M | 8M | 297.974M |
| Capital Expenditures | 16.439M | 17.254M | 44.9M | 24.197M | 25.007M |
| Change In Working Capital | -14.355M | -8.609M | 0.78M | -28.423M | -6.963M |
| Other Non Cash Items | -103.931M | 56.581M | 49.734M | 20.111M | 1.236M |
| Free Cash Flow | -25.019M | -33.577M | -45.657M | -26.048M | -16.881M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Coeli Circulus Am Micro & Sm Cp I FdrSek | 2 months ago | 590736 |
| 2. | Mirova Thematic Safety I/A USD | 1 year ago | 1523428 |
| 3. | Vanguard Total Stock Mkt Idx Inv | 2 months ago | 1492868 |
| 4. | iShares Russell 2000 ETF | 2 months ago | 1172612 |
| 5. | Alger Small Cap Focus Composite | 4 months ago | 1147505 |
| 6. | Alger Small Cap Focus I | 4 months ago | 1147505 |
| 7. | Xtrackers S&P 500 Swap ETF 1C | 5 months ago | 851901 |
| 8. | AXA Framlington Health Fund - R Income | 4 months ago | 635060 |
| 9. | Vanguard Institutional Extnd Mkt Idx Tr | 2 months ago | 576126 |
| 10. | Brown Capital Mgmt Small Co Inv | 2 months ago | 553757 |
| 11. | First Eagle Small Cap Opportunity I | 4 months ago | 512311 |
| 12. | Fidelity Small Cap Index | 4 months ago | 473437 |
| 13. | Invesco Technology S&P US Sel Sec ETF | 10 months ago | 385667 |
| 14. | Acuitas US Microcap Strategy | 5 months ago | 362179 |
| 15. | Needham Small Cap Growth Retail | 2 months ago | 360000 |
| 16. | Mirova Thematic Meta I/A USD | 1 year ago | 347541 |
| 17. | iShares Russell 2000 Value ETF | 2 months ago | 331226 |
| 18. | Russell 2000 Equity Index Fund B | 5 months ago | 313658 |
| 19. | First Eagle US Small Cap Strategy | 5 months ago | 274322 |
| 20. | Silvercrest U.S. Small Cap Growth | 2 months ago | 268981 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | Cadian Capital Management LP | 5 months ago | 4962552 |
| 2. | BlackRock Inc | 9 months ago | 3998405 |
| 3. | Millennium Management LLC | 5 months ago | 3244802 |
| 4. | Vanguard Group Inc | 5 months ago | 2905952 |
| 5. | Morgan Stanley - Brokerage Accounts | 9 months ago | 4611007 |
| 6. | Fred Alger Management, LLC | 5 months ago | 1754560 |
| 7. | Thematics Asset Management | 9 months ago | 1638623 |
| 8. | Assenagon Asset Management SA | 5 months ago | 1487403 |
| 9. | UBS Group AG | 9 months ago | 1331521 |
| 10. | Geode Capital Management, LLC | 5 months ago | 1199777 |
| 11. | Mak Capital One LLC | 5 months ago | 1199225 |
| 12. | Brown Capital Management, LLC | 5 months ago | 1112771 |
| 13. | Deutsche Bank AG | 5 months ago | 995991 |
| 14. | Dimensional Fund Advisors, Inc. | 5 months ago | 967605 |
| 15. | State Street Corp | 9 months ago | 963787 |
| 16. | Silvercrest Asset Management Group LLC | 5 months ago | 840529 |
| 17. | BNP Paribas Asset Management (Former AXA IM) | 9 months ago | 635060 |
| 18. | Meros Investment Management, LP | 5 months ago | 626427 |
| 19. | Bank of America Corp | 9 months ago | 521140 |
| 20. | Northern Trust Corp | 9 months ago | 486474 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...